Integrins protect cardiomyocytes from ischemia/reperfusion injury

Journal of Clinical Investigation

Volumn 123, Issue 10, 2013, Pages 4294-4308

  Okada, Hideshi ^a,b   Lai, N Chin ^a,b   Kawaraguchi, Yoshitaka ^c   Liao, Peter ^a,b   Copps, Jeffrey ^d   Sugano, Yasuo ^a,b   Okada Maeda, Sunaho ^c   Banerjee, Indroneal ^a   Schilling, Jan M ^c   Gingras, Alexandre R ^a   Asfaw, Elizabeth K ^a,b   Suarez, Jorge ^a   Kang, Seok Min ^a,b   Perkins, Guy A ^a   Au, Carol G ^a,b   Israeli Rosenberg, Sharon ^a,b   Manso, Ana Maria ^a,b   Liu, Zheng ^e   Milner, Derek J ^f   Kaufman, Stephen J ^f   Patel, Hemal H ^b,c   Roth, David M ^b,c   Hammond, H Kirk ^a,b   Taylor, Susan S ^d   Dillmann, Wolfgang H ^a,b   Goldhaber, Joshua I ^g   Ross, Robert S ^a,b   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c University of California   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WADSWORTH CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM BINDING PROTEIN; CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE; INTEGRIN; INTEGRIN RECEPTOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; RYANODINE RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 5; CALCIUM; INTEGRIN ALPHA7BETA1; PEPTIDE FRAGMENT; PROTEIN BINDING; PROTEIN SUBUNIT; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM BINDING; CELL DAMAGE; CELL MEMBRANE; CELL PROTECTION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOSOLIC FRACTION; ENERGY YIELD; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; REOXYGENATION; REPERFUSION INJURY; TRANSVERSE TUBULAR SYSTEM; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL HYPOXIA; CHEMISTRY; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SUBUNIT; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL HYPOXIA; CELLS, CULTURED; HUMANS; INTEGRINS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84885071787     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64216     Document Type: Article

References (71)

1. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011;301(5):H1723-H1741.
2. Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106(3):360-368.
3. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11-25.
4. Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci. 2002;115(pt 19):3729-3738.
5. Ross RS. Molecular and mechanical synergy: crosstalk between integrins and growth factor receptors. Cardiovasc Res. 2004;63(3):381-390.
6. Ross RS, Borg TK. Integrins and the myocardium. Circ Res. 2001;88(11):1112-1119.
7. Altruda F, et al. A human integrin beta 1 subunit with a unique cytoplasmic domain generated by alternative mRNA processing. Gene. 1990;95(2):261-266.
8. Languino LR, Ruoslahti E. An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. J Biol Chem. 1992;267(10):7116-7120.
9. Brancaccio M, Hirsch E, Notte A, Selvetella G, Lembo G, Tarone G. Integrin signalling: the tug-of-war in heart hypertrophy. Cardiovasc Res. 2006;70(3):422-433.
10. Anthis NJ, Wegener KL, Critchley DR, Campbell ID. Structural diversity in integrin/talin interactions. Structure. 2010;18(12):1654-1666.
11. Sun M, et al. Temporal response and localization of integrins beta1 and beta3 in the heart after myocardial infarction: regulation by cytokines. Circulation. 2003;107(7):1046-1052.
12. Roman J, Little CW, McDonald JA. Potential role of RGD-binding integrins in mammalian lung branching morphogenesis. Development. 1991;112(2):551-558.
13. Roman J, McDonald JA. Expression of fibronectin, the integrin alpha 5, and alpha-smooth muscle actin in heart and lung development. Am J Respir Cell Mol Biol. 1992;6(5):472-480.
14. Nawata J, et al. Differential expression of alpha 1, alpha 3 and alpha 5 integrin subunits in acute and chronic stages of myocardial infarction in rats. Cardiovasc Res. 1999;43(2):371-381.
15. Brancaccio M, et al. Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development. Cell Adhes Commun. 1998;5(3):193-205.
16. van der Flier A, et al. Spatial and temporal expression of the beta1D integrin during mouse development. Dev Dyn. 1997;210(4):472-486.
17. Wu RX, et al. Fibroblast migration after myocardial infarction is regulated by transient SPARC expression. J Mol Med (Berl). 2006;84(3):241-252.
18. Krishnamurthy P, Subramanian V, Singh M, Singh K. Deficiency of beta1 integrins results in increased myocardial dysfunction after myocardial infarction. Heart. 2006;92(9):1309-1315.
19. Li R, et al. beta1 integrin gene excision in the adult murine cardiac myocyte causes defective mechanical and signaling responses. Am J Pathol. 2012;180(3):952-962.
20. Shai SY, et al. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res. 2002;90(4):458-464.
21. Sohal DS, et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89(1):20-25.
22. Nagai T, Sawano A, Park ES, Miyawaki A. Circularly permuted green fluorescent proteins engineered to sense Ca2+. Proc Natl Acad Sci U S A. 2001;98(6):3197-3202.
23. Belke DD, Swanson E, Suarez J, Scott BT, Stenbit AE, Dillmann WH. Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose. Am J Physiol Heart Circ Physiol. 2007;292(4):H1755-H1763.
24. Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta. 2009;1787(11):1402-1415.
25. Juhaszova M, et al. The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann N Y Acad Sci. 2008;1123:197-212.
26. Kim JS, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2006;290(5):H2024-H2034.
27. Clark RB, Tremblay A, Melnyk P, Allen BG, Giles WR, Fiset C. T-tubule localization of the inward-rectifier K (+) channel in mouse ventricular myocytes: a role in K (+) accumulation. J Physiol. 2001;537(pt 3):979-992.
28. Wei S, et al. T-tubule remodeling during transition from hypertrophy to heart failure. Circ Res. 2010;107(4):520-531.
29. Zalk R, Lehnart SE, Marks AR. Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem. 2007;76:367-385.
30. Tung CC, Lobo PA, Kimlicka L, Van Petegem F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature. 2010;468(7323):585-588.
31. Bosanac I, et al. Structure of the inositol 1, 4, 5-trisphosphate receptor binding core in complex with its ligand. Nature. 2002;420(6916):696- 700.
32. Bosanac I, Yamazaki H, Matsu-Ura T, Michikawa T, Mikoshiba K, Ikura M. Crystal structure of the ligand binding suppressor domain of type 1 inositol 1, 4, 5-trisphosphate receptor. Mol Cell. 2005;17(2):193-203.
33. Ponting CP. Novel repeats in ryanodine and IP3 receptors and protein O-mannosyltransferases. Trends Biochem Sci. 2000;25(2):48-50.
34. Ikemoto N, Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors. Front Biosci. 2002;7:d671-d683.
35. Priori SG, Chen SR. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res. 2011;108(7):871-883.
36. Liu Z, et al. Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor. J Cell Sci. 2010;123(pt 10):1775-1784.
37. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene - a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59(4):364-373.
38. Liu J, Burkin DJ, Kaufman SJ. Increasing alpha 7 beta 1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression. Am J Physiol Cell Physiol. 2008;294(2):C627-C640.
39. Liu J, Milner DJ, Boppart MD, Ross RS, Kaufman SJ. beta1D chain increases alpha7beta1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Hum Mol Genet. 2012;21(7):1592-1603.
40. Burkin DJ, Kaufman SJ. The α7β1 integrin in muscle development and disease. Cell Tissue Res. 1999;296(1):183-190.
41. Vachon PH, et al. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest. 1997;100(7):1870-1881.
42. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem. 1989;264(1):380-388.
43. Kostin S, et al. The internal and external protein scaffold of the T-tubular system in cardiomyocytes. Cell Tissue Res. 1998;294(3):449-460.
44. Nakayama H, et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest. 2007;117(9):2431-2444.
45. Marx SO, et al. PKA phosphorylation dissociates FKBP12. 6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101(4):365-376.
46. Carter S, Colyer J, Sitsapesan R. Maximum phosphorylation of the cardiac ryanodine receptor at serine-2809 by protein kinase a produces unique modifications to channel gating and conductance not observed at lower levels of phosphorylation. Circ Res. 2006;98(12):1506-1513.
47. Wehrens XH, et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science. 2004;304(5668):292-296.
48. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Terentyeva R, Gyorke S. Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes. J Physiol. 2003;552(pt 1):109-118.
49. Lokuta AJ, Rogers TB, Lederer WJ, Valdivia HH. Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation-dephosphorylation mechanism. J Physiol. 1995;487(pt 3):609-622.
50. Zhang H, et al. Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction. Circ Res. 2012;110(6):831-840.
51. Bernardi P, Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr. 1996;28(2):131-138.
52. Crompton M, Costi A, Hayat L. Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J. 1987;245(3):915-918.
53. 2+ trigger site. Arch Biochem Biophys. 1979;195(2):460-467.
54. Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol. 2000;529(pt 1):37-47.
55. Szalai G, Csordas G, Hantash BM, Thomas AP, Hajnoczky G. Calcium signal transmission between ryanodine receptors and mitochondria. J Biol Chem. 2000;275(20):15305-15313.
56. Dorn GW, Maack C. SR and mitochondria: calcium cross-talk between kissing cousins. J Mol Cell Cardiol. 2013;55:42-49.
57. Kohlhaas M, Maack C. Calcium release microdomains and mitochondria. Cardiovasc Res. 2013;98(2):259-268.
58. Gomez AM, et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276(5313):800-806.
59. Ikemoto N, Yamamoto T. Postulated role of inter-domain interaction within the ryanodine receptor in Ca (2+) channel regulation. Trends Cardiovasc Med. 2000;10(7):310-316.
60. Tateishi H, et al. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts. Cardiovasc Res. 2009;81(3):536-545.
61. Boys JA, Toledo AH, Anaya-Prado R, Lopez-Neblina F, Toledo-Pereyra LH. Effects of dantrolene on ischemia-reperfusion injury in animal models: a review of outcomes in heart, brain, liver, and kidney. J Investig Med. 2010;58(7):875-882.
62. Kocogullari CU, et al. Can dantrolene protect spinal cord against ischemia/reperfusion injury? An experimental study. Thorac Cardiovasc Surg. 2008;56(7):406-411.
63. Preckel B, Schlack W, Comfere T, Thamer V. Effect of dantrolene in an in vivo and in vitro model of myocardial reperfusion injury. Acta Anaesthesiol Scand. 2000;44(2):194-201.
64. van der Flier A, Kuikman I, Baudoin C, van der Neut R, Sonnenberg A. A novel β-1 integrin isoform produced by alternative splicing: unique expression in cardiac and skeletal muscle. FEBS Lett. 1995;369(2-3):340-344.
65. Liu S, Calderwood DA, Ginsberg MH. Integrin cytoplasmic domain-binding proteins. J Cell Sci. 2000;113(pt 20):3563-3571.
66. Millon-Frémillon A, et al. CaMKII-mediated intramolecular opening of integrin cytoplasmic domain associated protein-1 (ICAP-1α) negatively regulates β1 integrins. J Biol Chem. 2013;288(28):20248-20260.
67. Zucchi R, Ronca F, Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther. 2001;89(1):47-65.
68. Song WK, Wang W, Foster RF, Bielser DA, Kaufman SJ. H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol. 1992;117(3):643-657.
69. Pham CG, et al. Striated muscle-specific beta (1D) - integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol Heart Circ Physiol. 2000;279(6):H2916-H2926.
70. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266(36):24613-24620.
71. Horikawa YT, et al. Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol. 2008;44(1):123-130.